Study: NCT03044977

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-3-Tyr-Octreotide
Description: Peptide receptor radiotherapy (PRRT) using Yttrium-90 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-3-Tyr-Octreotide
Description: Peptide receptor radiotherapy (PRRT) using Yttrium-90 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-3-Tyr-Octreotide
Description: Peptide receptor radiotherapy (PRRT) using Yttrium-90 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-3-Tyr-Octreotide
Description: Peptide receptor radiotherapy (PRRT) using Yttrium-90 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-3-Tyr-Octreotide
Description: Peptide receptor radiotherapy (PRRT) using Yttrium-90 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-3-Tyr-Octreotide
Description: Peptide receptor radiotherapy (PRRT) using Yttrium-90 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-3-Tyr-Octreotide
Description: Peptide receptor radiotherapy (PRRT) using Yttrium-90 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-3-Tyr-Octreotide
Description: Peptide receptor radiotherapy (PRRT) using Yttrium-90 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131I-MIBG
Description: Peptide receptor radiotherapy (PRRT) using Iodine-131 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131I-MIBG
Description: Peptide receptor radiotherapy (PRRT) using Iodine-131 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131I-MIBG
Description: Peptide receptor radiotherapy (PRRT) using Iodine-131 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131I-MIBG
Description: Peptide receptor radiotherapy (PRRT) using Iodine-131 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131I-MIBG
Description: Peptide receptor radiotherapy (PRRT) using Iodine-131 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131I-MIBG
Description: Peptide receptor radiotherapy (PRRT) using Iodine-131 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131I-MIBG
Description: Peptide receptor radiotherapy (PRRT) using Iodine-131 as the active radionuclide. For intravenous administration only.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131I-MIBG
Description: Peptide receptor radiotherapy (PRRT) using Iodine-131 as the active radionuclide. For intravenous administration only.